HORIZON-MISS-2024-CANCER-01-01

Use cases for the UNCAN.eu research data platform -

Related topics

Drag to rearrange · hover a topic or connection to preview why it's linked, click to pin that panel open

Topics in this graph

Bold node = current topic · node color = call status · hover for details, click to pin · smaller, lighter topics are two steps away

Call text (as on F&T portal)

View on F&T portal
Expected Outcome:

The aim of this topic is to operationalise the UNCAN.eu research data platform foreseen in the Cancer Mission implementation plan[1], through a series of use-cases. To this goal, proposals are expected to develop tools supporting researchers to access, manage and analyse cancer digital data, building among others on resources developed by EOSC4cancer[2].

 Proposal(s) under this topic are expected to contribute to all of the following outcomes:

  • The UNCAN.eu platform is developed by federating a network of cancer data nodes built on European and national computing infrastructures that link different cancer data holders across European countries.
  • Use-cases focusing on the understanding of cancer initiation and progression are designed and implemented by multidisciplinary teams to develop tools and services for working with FAIR data.
  • Researchers and clinicians use the electronic resources provided by the UNCAN.eu platform to access, manage and analyse data of heterogeneous types and belonging to different research domains at an unprecedented scale.
Scope:

The successful proposal should:

  • Develop the UNCAN.eu platform by integrating and, where relevant, complementing existing or planned data nodes of European research infrastructures and/or other national infrastructures that may link various cancer data holders across Member States and Associated Countries (e.g. hospitals, research centres, comprehensive cancer centres, etc.). The number of Member States involved should be sufficient to demonstrate scalability and flexibility of the UNCAN.eu platform while allowing for stepwise onboarding of more countries.
  • Provide tools, services and workflows to researchers across data nodes for dataset creation, standardisation, data discovery, secure access, management, visualization, harmonization, analysis and other functions as appropriate. This task should capitalise on EOSC4cancer's achievements, integrating and expanding as appropriate the available tools and solutions. It should also take advantage of the European Health Data Space and the European Open Science Cloud frameworks.
  • Design and implement a rich and diverse portfolio of use-cases to inform, steer the development and demonstrate the validity of the UNCAN.eu platform. Use cases should focus on research questions that are in line with the Cancer Mission objectives and that may advance the understanding of mechanisms involved in cancer development and progression beyond the current state of the art. At least one use-case should target a cancer type with a 5-year overall survival of less than 50% from the time of diagnosis. A second use-case should target paediatric cancer.
  • At the same time, use-cases should be functional to the design and implementation of UNCAN.eu to increase the diversity of digital tools and services available for cancer researchers. The mobilisation and integration of a large amount of research and real word data beyond current practice and a balanced participation of clinicians, disease experts and data scientists will be essential to achieve the objectives of this topic. Due attention should be paid to sex and gender, disaggregating the data as appropriate.
  • The successful consortium should develop innovative approaches, to integrate and analyse heterogeneous data from multiple sources and different research domains[3], including the participation of the necessary interdisciplinary set of European infrastructures and national data nodes. In this regard, at least one use-case should integrate imaging, digital pathology and genomic data, using and/or contributing with new data sources to the Genomics Data Infrastructure (GDI)[4] and Cancer Image Europe (EUCAIM)[5].
  • Give emphasis to data being managed and shared in line with the FAIR principles, and the concept of FAIR-by-design is applied wherever possible. The applicants must demonstrate that the necessary data sources are, or will be, effectively and timely available. During the project lifetime, new data sources that might become available at a later stage can be accommodated as well as allowing additional data holders to join the UNCAN.eu platform. Results must be open source and made available through a public repository under a permissive license. Open access data should be provided whenever possible.
  • Give due consideration to, and establish appropriate links with, EU-funded initiatives such as EHDS-related governance and implementation actions[6], the European Network of Cancer Registries[7].
  • Foresee to establish links with the successful proposal resulting from the topic HORIZON-MISS-2024-CANCER-01-02 ‘Support dialogue towards the development of national cancer data nodes'.

This topic requires the effective contribution of SSH disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, to produce meaningful and significant effects enhancing the societal impact of the related research activities.

The Commission will facilitate coordination. Therefore, proposals should include a budget for networking, attendance at meetings, and potential joint activities without the prerequisite to give details of these at this stage. Examples are organising joint workshops, establishing best practices, joint communication or citizen engagement activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate.

Successful proposal will be asked to join the 'Understanding' cluster for the Mission on Cancer established in 2022[8]. The details of joint activities will be defined during the grant agreement preparation phase and during the life of the project.

[1] https://research-and-innovation.ec.europa.eu/system/files/2021-09/cancer_implementation_plan_for_publication_final_v2.pdf

[2] https://eosc4cancer.eu/

[3] Including – but not limiting to – genomics and other omics data, digital pathology, real world data, cancer registries, patient-derived cancer models, lifestyle, socio-economic, occupational and environmental data. In each use-case integration of clinical data from different sources is required.

[4] https://gdi.onemilliongenomes.eu/

[5] https://cancerimage.eu/

[6] https://ehds2pilot.eu/

[7] https://encr.eu/

[8] In order to address the objectives of the Mission on Cancer, participants will collaborate in project clusters to leverage EU-funding, increase networking across sectors and disciplines, and establish a portfolio of Cancer Mission R&I and policy actions.

News flashes

2026-10-08

HORIZON-MISS-2024-CANCER-01-01

Published: 18 April 2024

Deadline: 18 September 2024

Available budget: EUR 30,000,000.00

We recently informed the applicants about the evaluation results for their proposals.

Number of proposals submitted (including proposals transferred from or to other calls): 3

Number of inadmissible proposals: 0

Number of ineligible proposals: 0

Number of above-threshold proposals: 2

Total budget requested for above-threshold proposals: € 59,935,675.50

Number of proposals retained for funding: 1

Number of proposals in the reserve list: 1

Funding threshold: 14.0

Number of proposals with scores lower or equal to 15 and higher or equal to 14: 1

Number of proposals with scores lower than 14 and higher or equal to 13: 0

Number of proposals with scores lower than 13 and higher or equal to 12: 1

Summary of observer’s report:

The HORIZON-HLTH-2024-DISEASE-09 (EUR 100 million) and HORIZON-MISS-2024-CANCER-01 (EUR 119 million) evaluations took place between October and November 2024. These strategically important Horizon Europe calls were evaluated using the European Commission’s evaluation IT system SEP. A total of 86 eligible applications were evaluated by experts from Europe and around the world.

They had expertise in public health, life sciences, private sector, artificial intelligence (AI), gender, social sciences & humanities (SSH), clinical trials, anti-microbial resistance (AMR), child, adolescent and young adult (CAYA) cancer research, innovation, health technology assessment (HTA), health economy, healthcare, etc. This resulted in the ranking of proposals to be funded using EU standard ranking evaluation and topic-specific ranking mechanisms.

The call evaluation process was fair, transparent, and robust. Every step of the evaluation followed the rules, guidelines and decision-making processes required for the proper evaluation of EU calls. Across all panels, experts highlighted the opportunity to leverage their know-how to give more detailed feedback to the applicants.

An underlying value of the expert group was the continuous engagement throughout the evaluation process to do the right thing for health in Europe and for citizens to ensure that the best proposals were recommended for funding. A systemic examination of documentation, communication processes and report quality combined with observing meetings and individual and group feedback demonstrated that the current process was robust. There is potential to adapt and plan the evaluation process considering the increasing quantity and quality of applications the EU receives. This may include increasing the quality of the briefing material included in the documentation, providing more detailed guidance on horizontal evaluation aspects, and reinforcing the role of recorders and how they should interact with the moderators and the evaluators.

For questions, please contact the Research Enquiry Service.

2026-10-08

Call HORIZON-MISS-2024-CANCER-01 closed on 18 September 2024.

90 proposals have been submitted.

The breakdown per topic is:

  • HORIZON-MISS-2024-CANCER-01-01: 3 proposals
  • HORIZON-MISS-2024-CANCER-01-02: 4 proposals
  • HORIZON-MISS-2024-CANCER-01-03: 33 proposals
  • HORIZON-MISS-2024-CANCER-01-04: 2 proposals
  • HORIZON-MISS-2024-CANCER-01-05: 42 proposals
  • HORIZON-MISS-2024-CANCER-01-06: 6 proposals

Evaluation results are expected to be communicated in late December 2024.

2026-10-08

HORIZON-MISS-2024-CANCER-01-01

Published: 18 April 2024

Deadline: 18 September 2024

Available budget: EUR 30,000,000.00

We recently informed the applicants about the evaluation results for their proposals.

Number of proposals submitted (including proposals transferred from or to other calls): 3

Number of inadmissible proposals: 0

Number of ineligible proposals: 0

Number of above-threshold proposals: 2

Total budget requested for above-threshold proposals: € 59,935,675.50

Number of proposals retained for funding: 1

Number of proposals in the reserve list: 1

Funding threshold: 14.0

Number of proposals with scores lower or equal to 15 and higher or equal to 14: 1

Number of proposals with scores lower than 14 and higher or equal to 13: 0

Number of proposals with scores lower than 13 and higher or equal to 12: 1

Summary of observer’s report:

The HORIZON-HLTH-2024-DISEASE-09 (EUR 100 million) and HORIZON-MISS-2024-CANCER-01 (EUR 119 million) evaluations took place between October and November 2024. These strategically important Horizon Europe calls were evaluated using the European Commission’s evaluation IT system SEP. A total of 86 eligible applications were evaluated by experts from Europe and around the world.

They had expertise in public health, life sciences, private sector, artificial intelligence (AI), gender, social sciences & humanities (SSH), clinical trials, anti-microbial resistance (AMR), child, adolescent and young adult (CAYA) cancer research, innovation, health technology assessment (HTA), health economy, healthcare, etc. This resulted in the ranking of proposals to be funded using EU standard ranking evaluation and topic-specific ranking mechanisms.

The call evaluation process was fair, transparent, and robust. Every step of the evaluation followed the rules, guidelines and decision-making processes required for the proper evaluation of EU calls. Across all panels, experts highlighted the opportunity to leverage their know-how to give more detailed feedback to the applicants.

An underlying value of the expert group was the continuous engagement throughout the evaluation process to do the right thing for health in Europe and for citizens to ensure that the best proposals were recommended for funding. A systemic examination of documentation, communication processes and report quality combined with observing meetings and individual and group feedback demonstrated that the current process was robust. There is potential to adapt and plan the evaluation process considering the increasing quantity and quality of applications the EU receives. This may include increasing the quality of the briefing material included in the documentation, providing more detailed guidance on horizontal evaluation aspects, and reinforcing the role of recorders and how they should interact with the moderators and the evaluators.

For questions, please contact the Research Enquiry Service.

2026-10-08

Call HORIZON-MISS-2024-CANCER-01 closed on 18 September 2024.

90 proposals have been submitted.

The breakdown per topic is:

  • HORIZON-MISS-2024-CANCER-01-01: 3 proposals
  • HORIZON-MISS-2024-CANCER-01-02: 4 proposals
  • HORIZON-MISS-2024-CANCER-01-03: 33 proposals
  • HORIZON-MISS-2024-CANCER-01-04: 2 proposals
  • HORIZON-MISS-2024-CANCER-01-05: 42 proposals
  • HORIZON-MISS-2024-CANCER-01-06: 6 proposals

Evaluation results are expected to be communicated in late December 2024.

2024-04-18
The submission session is now available for: HORIZON-MISS-2024-CANCER-01-01(HORIZON-RIA), HORIZON-MISS-2024-CANCER-01-04(HORIZON-CSA), HORIZON-MISS-2024-CANCER-01-02(HORIZON-CSA), HORIZON-MISS-2024-CANCER-01-03(HORIZON-IA), HORIZON-MISS-2024-CANCER-01-05(HORIZON-RIA), HORIZON-MISS-2024-CANCER-01-06(HORIZON-IA)
2024-04-18
The submission session is now available for: HORIZON-MISS-2024-CANCER-01-01(HORIZON-RIA), HORIZON-MISS-2024-CANCER-01-04(HORIZON-CSA), HORIZON-MISS-2024-CANCER-01-02(HORIZON-CSA), HORIZON-MISS-2024-CANCER-01-03(HORIZON-IA), HORIZON-MISS-2024-CANCER-01-05(HORIZON-RIA), HORIZON-MISS-2024-CANCER-01-06(HORIZON-IA)
call topic details
Call status: Closed
Opening date: 2024-04-18 (2 years ago)
Closing date: 2024-09-18 (2 years ago)
Procedure: single-stage

Budget: 30,000,000
Expected grants: 1
Contribution: 30,000,000 - 30,000,000
News flashes

This call topic has been appended 6 times by the EC with news.

  • 2026-10-08
    horizon-miss-2024-cancer-01-01published:...
  • 2026-10-08
    call horizon-miss-2024-cancer-01 closed...
  • 2026-10-08
    horizon-miss-2024-cancer-01-01published:...
  • 2026-10-08
    call horizon-miss-2024-cancer-01 closed...
  • 2024-04-18
    the submission session is now available...
  • 2024-04-18
    the submission session is now available...
Call

HORIZON-MISS-2024-CANCER-01

Call topics are often grouped together in a call. Sometimes this is for a thematic reason, but often it is also for practical reasons.

There are 5 other topics in this call:

Source information

Showing the latest information. Found 6 versions of this call topic in the F&T portal.

Information from

  • 2025-07-02_03-33-03
  • 2025-02-06_03-30-17
  • 2024-11-23_03-30-16
  • 2024-11-04_17-25-10
  • 2024-09-30_21-20-58
  • 2024-07-11_18-29-25

Check the differences between the versions.

Annotations

You must be logged in to add annotations
No annotations yet

Events

Hand-picked events relevant to this call topic.

No events yet

There are currently no events linked to this call topic.

Timeline

Track where this call stands in its lifecycle, from work programme to grant signature, and see what's likely to happen next.

Grant agreement signed · 18 May 2025 (1 year ago)

All expected milestones for this call have passed.

Today

Work programme published

18 Feb 2024 · est.

Call opens

18 Apr 2024

Call closes

18 Sep 2024

Call published

30 Sep 2024

Outcome expected

18 Feb 2025 · est.

Grant agreement signed

18 May 2025 · est.

Preparation Open for submission Evaluation Grant preparation Not yet reached
  1. Work programme published Estimated

    18 Feb 2024 · 2 years ago

    Topics are listed in the Work Programme before the call opens. Spotting this early gives you a head start on partner search and proposal planning.

  2. Call opens

    18 Apr 2024 · 2 years ago

    Submissions can be made from this date.

  3. Call closes

    18 Sep 2024 · 2 years ago

    Deadline to submit a proposal.

  4. Call published

    30 Sep 2024 · 2 years ago

    This topic was first published in TopicTree.

  5. Outcome expected Estimated

    18 Feb 2025 · 1 year ago

    The maximum time to inform applicants of the evaluation outcome is five months after the call closes.

  6. Grant agreement signed Estimated

    18 May 2025 · 1 year ago

    The maximum time to sign the grant agreement is three months after applicants are informed of the outcome.

Funded Projects

Loading...

Project information comes from CORDIS (for Horizon 2020 and Horizon Europe) and will be sourced from F&T Portal (for Digital Europe projects)

Ecosystem bubbles

This call topic is part of the following thematic bubbles.

Not part of a bubble yet

This call topic has not been grouped into an ecosystem bubble.

Call document info

This section will come soon and contain the scraped information from the call document, such as the expected impact, scope, and other relevant sections. In the meantime, you can find this information in the call text section or directly on the F&T portal. View on F&T portal